Tuberculosis vaccine development: goals, immunological design, and evaluation

Summary A third of the worldʹs population is infected with Mycobacterium tuberculosis, and 2 million people die from tuberculosis every year even though the bacille Calmette Guérin (BCG) vaccine has been available for more than 75 years. In order to reduc